A detailed history of Chesapeake Wealth Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chesapeake Wealth Management holds 16,361 shares of MRK stock, worth $1.59 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
16,361
Previous 16,117 1.51%
Holding current value
$1.59 Million
Previous $2 Million 6.92%
% of portfolio
0.64%
Previous 0.73%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $27,120 - $31,468
244 Added 1.51%
16,361 $1.86 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $68,709 - $73,792
-555 Reduced 3.33%
16,117 $2 Million
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $23,327 - $27,181
206 Added 1.25%
16,672 $2.2 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $34,261 - $37,284
-342 Reduced 2.03%
16,466 $1.8 Million
Q3 2023

Nov 16, 2023

BUY
$102.95 - $114.33 $1,647 - $1,829
16 Added 0.1%
16,808 $1.73 Million
Q2 2023

Aug 01, 2023

BUY
$108.61 - $118.38 $71,030 - $77,420
654 Added 4.05%
16,792 $1.94 Million
Q1 2023

Apr 25, 2023

BUY
$102.94 - $114.86 $80,396 - $89,705
781 Added 5.09%
16,138 $1.72 Million
Q4 2022

Feb 23, 2023

BUY
$87.44 - $112.11 $192,368 - $246,642
2,200 Added 16.72%
15,357 $1.7 Million
Q3 2022

Oct 28, 2022

BUY
$84.53 - $94.96 $589,174 - $661,871
6,970 Added 112.66%
13,157 $1.13 Million
Q2 2022

Jul 21, 2022

BUY
$83.49 - $94.64 $39,490 - $44,764
473 Added 8.28%
6,187 $564,000
Q1 2022

Apr 19, 2022

SELL
$73.51 - $82.4 $39,768 - $44,578
-541 Reduced 8.65%
5,714 $469,000
Q4 2021

Feb 03, 2022

BUY
$72.28 - $90.54 $1,373 - $1,720
19 Added 0.3%
6,255 $479,000
Q3 2021

Oct 26, 2021

SELL
$71.68 - $78.83 $59,136 - $65,034
-825 Reduced 11.68%
6,236 $469,000
Q2 2021

Jul 29, 2021

SELL
$70.31 - $77.77 $29,741 - $32,896
-423 Reduced 5.65%
7,061 $549,000
Q1 2021

Apr 26, 2021

SELL
$68.86 - $81.11 $366,954 - $432,235
-5,329 Reduced 41.59%
7,484 $577,000
Q4 2020

Feb 05, 2021

SELL
$71.77 - $79.65 $156,386 - $173,557
-2,179 Reduced 14.53%
12,813 $1.05 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $442,153 - $501,183
-6,042 Reduced 28.72%
14,992 $1.24 Million
Q2 2020

Aug 11, 2020

SELL
$70.42 - $80.13 $276,609 - $314,750
-3,928 Reduced 15.74%
21,034 $1.63 Million
Q1 2020

Apr 29, 2020

BUY
$63.36 - $87.82 $9,567 - $13,260
151 Added 0.61%
24,962 $1.92 Million
Q4 2019

Jan 29, 2020

BUY
$77.58 - $87.54 $94,802 - $106,973
1,222 Added 5.18%
24,811 $2.26 Million
Q3 2019

Oct 25, 2019

BUY
$76.08 - $82.93 $36,518 - $39,806
480 Added 2.08%
23,589 $1.99 Million
Q2 2019

Aug 01, 2019

BUY
$69.84 - $81.59 $169,222 - $197,692
2,423 Added 11.71%
23,109 $1.94 Million
Q1 2019

Apr 17, 2019

BUY
$69.58 - $79.36 $111,467 - $127,134
1,602 Added 8.39%
20,686 $1.72 Million
Q4 2018

Feb 06, 2019

BUY
$65.24 - $75.71 $215,031 - $249,540
3,296 Added 20.88%
19,084 $1.46 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $38,709 - $45,520
671 Added 4.44%
15,788 $1.12 Million
Q2 2018

Aug 07, 2018

BUY
$50.83 - $59.72 $121,839 - $143,148
2,397 Added 18.84%
15,117 $917,000
Q1 2018

Jun 04, 2018

BUY
$50.96 - $59.23 $648,211 - $753,405
12,720 New
12,720 $693,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Chesapeake Wealth Management Portfolio

Follow Chesapeake Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.